表紙:局所麻酔薬の世界市場 (2021-2028年)
市場調査レポート
商品コード
977297

局所麻酔薬の世界市場 (2021-2028年)

Global Local Anesthesia Drugs Market - 2021-2028

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.08円
局所麻酔薬の世界市場 (2021-2028年)
出版日: 2021年07月15日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界における局所麻酔薬市場の成長は、手術数の急増によって推進されています。コンピューターベースの局所麻酔薬デリバリーや振動触覚デバイスなどのドラッグデリバリーの改善も、予測期間中に世界の局所麻酔薬市場を後押しすると推定されています。

高齢者人口の急増、心血管・呼吸器系関連疾患の有病率の上昇などの要因は、市場の成長を推進する重要な要因です。ドラッグデリバリー技術の進歩も、外科手術における局所麻酔薬の需要に貢献することが期待されています。たとえば、DepoFoam technologyは、新しい方法を使用してブピバカインを送達し、術後の疼痛管理に非常に効率的です。局所麻酔薬の市場の成長は、アーティカイン、レボブピバカイン、ロピバカインなどの新しく効果的な薬のイントロダクションよっても促進されています。

一方、心血管毒性、CNS毒性、呼吸抑制などの薬物によるいくつかの主要な副作用は、世界の局所麻酔薬市場における抑制要因となっています。

当レポートでは、世界の局所麻酔薬市場について調査し、市場の概要、各セグメントおよび地域別の市場分析と予測、競合情勢の分析、主要企業のプロファイルなどを提供しています。

目次

第1章 世界の局所麻酔薬市場:調査手法・範囲

  • 調査手法
  • 調査目的・調査範囲

第2章 世界の局所麻酔薬市場:市場定義・概要

第3章 世界の局所麻酔薬市場:エグゼクティブサマリー

  • 市場内訳:医薬品クラス別
  • 市場内訳:投与経路別
  • 市場内訳:流通チャネル別
  • 市場内訳:地域別

第4章 世界の局所麻酔薬市場:市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界の局所麻酔薬市場:業界分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 償還分析
  • アンメットニーズ

第6章 世界の局所麻酔薬市場:COVID-19分析

  • 市場におけるCovid-19の分析
    • COVID-19:以前の市場シナリオの前
    • COVID-19:現在の市場シナリオ
    • COVID-19:以降または将来のシナリオ
  • Covid-19における価格のダイナミクス
  • 需要と供給のスペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界の局所麻酔薬市場:医薬品クラス別

  • イントロダクション
  • 市場規模分析・前年比成長分析(%):医薬品クラス別
  • 市場魅力指数:医薬品クラス別
    • ブピバカイン
    • リドカイン
    • ベンゾカイン
    • ロピバカイン
    • プリロカイン
    • クロロプロカイン
    • その他

第8章 世界の局所麻酔薬市場:投与経路別

  • イントロダクション
  • 市場規模分析・前年比成長分析(%):投与経路別
  • 市場魅力指数:投与経路別
    • 注射薬
    • 表面麻酔薬

第9章 世界の局所麻酔薬市場:流通チャネル別

  • イントロダクション
  • 市場規模分析・前年比成長分析(%):流通チャネル別
  • 市場魅力指数:流通チャネル別
    • 病院薬局
    • 薬局
    • その他

第10章 世界の局所麻酔薬市場:地域別

  • イントロダクション
  • 市場規模分析・前年比成長分析(%):地域別
  • 市場魅力指数:地域別
  • 北米
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析・前年比成長分析(%):医薬品クラス別
    • 市場規模分析・前年比成長分析(%):投与経路別
    • 市場規模分析・前年比成長分析(%):流通チャネル別
    • 市場規模分析・前年比成長分析(%):国別
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ

第11章 世界の局所麻酔薬市場:競合情勢

  • 競合シナリオ
  • 市場ポジショニング/シェア分析
  • 合併と買収の分析

第12章 世界の局所麻酔薬市場:企業プロファイル

  • Fresenius Kabi USA, LLC
  • Novartis International AG.
  • Pfizer Inc.
  • Advanced Pharma, Inc.
  • Akorn, Inc.
  • Teva Pharmaceutical Industries Ltd.,
  • Akorn, Inc.
  • Glenmark Pharmaceuticals, Inc.
  • Baxter international, Inc.
  • Sandoz Inc.

第13章 重要考察

第14章 DataM

  • 付録
  • 当社・サービスについて
  • お問い合わせ
目次
Product Code: DMPH2900

Market Overview

The global local anesthesia drugs market size was valued US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Local anesthesia is the temporary loss of sensation in a particular body part, or a localized areas. Local anesthesia drugs are given in order to treat the painful situations for the elimination of pain while performing any major or some minor surgeries, or also to eliminate pain post-surgery.

Market Dynamics

The surge in cases drives the global-local anesthesia drugs market growth to perform surgeries and improve drug delivery. Computer-based local anesthetic delivery and vibrotactile devices are estimated to boost the global-local anesthesia drugs market's forecast period.

The increase in the number of surgeries is expected to drive growth in the forecast period

Anesthesia is one of the essential components of any surgical procedure. It induces temporary unconsciousness and loss of protective reflexes. According to the Centers for Disease Control and Prevention (CDC), more than 51 million inpatient surgeries and 53 million outpatient surgeries were performed in the United States in 2017. Cardiology, surgical, and obstetrical procedures were the most common ones. In Europe, many surgeries are being performed for cases of cataracts, tonsillectomy, colonoscopy, cesarean sections, and hip replacements. Besides, several procedures, such as cochlear implantation, laparoscopic colectomy, laparoscopic hysterectomy, secondary hip replacement, and knee replacement, have become more frequent in recent years. Hence, the overall increase in the number of surgeries performed has a strong impact on the anesthetic drug market. These drugs are used in all surgical procedures to reduce pain during surgery.

Rising prevalence of cardiovascular and respiratory system-related diseases expected to drive the market growth

Factors such as the rapid rise in the aging population, rising prevalence of cardiovascular and respiratory system-related diseases are key factors driving the market's growth. The state allows surgical operations and other medical processes to be carried out on patients without causing them undue distress or discomfort. Surgical operations of the eyes are performed using a wide variety of anesthetic techniques. Advancements in drug delivery technologies are also expected to contribute to the demand for local anesthetics in surgical procedures. For instance, DepoFoam technology uses a new method to deliver bupivacaine and is very efficient in managing post-operative pain. The market growth for local anesthesia drugs is also fueled by introducing new and effective drugs such as articaine, levobupivacaine, and ropivacaine. This growth is supplemented by increasing healthcare expenditure in developing countries such as India, China, and Brazil, where the number of surgeries performed has been on a steady rise. These factors are driving the growth of the market in the forecast period.

The major side effects of drugs are likely to hinder the market growth.

However, some major side effects of drugs, such as cardiovascular toxicity, CNS toxicity, and respiratory depression, are among the significant factors that pull back the market to achieve its full potential in the global-local anesthesia drugs market.

COVID-19 Impact Analysis

Several quick changes in response to COVID-19 have had an immediate impact on local anesthesia drugs and their practices. While some of the disruptions are temporary, others will persist over the longer term. Economic shocks are already evident for the supply chain and anesthesia workforce, and some temporary shocks may return with anticipated future waves of COVID-19. The first and most challenging impacts are due to the canceling or postponement of non-essential surgical procedures. This reduction has a direct negative financial impact on anesthesiology practices and can lead to workforce reductions for practices that specialize in these types of procedures. Different anesthesia methods may be required to reduce medications use to support patients on ventilators for procedures that are still being performed. Nerve blocks and local anesthesia are other options that can be considered. Another disruption is the surging demand for non-essential procedures that have been delayed by the pandemic. Once the pandemic wanes, procedures that have been postponed will need to be rescheduled along with others. This will lead to an increased demand for the local anesthesia drugs market.

Segment Analysis

The bupivacaine segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

Bupivacaine is a local anesthetic drug that has been used in various surgical procedures. This is helpful in blocking the nerve impulses that send pain signals to the brain. As per the Royal College of Surgeons, in England (U.K), there were around 4.7 million surgical admissions in 2013/14. There has been a 27% increase in the number of admissions for surgical procedures between 2003-2004 and 2013-14. The most common surgical procedures are hernia repairs, hip replacement, knee replacement, gall bladder removal, and tonsillectomies.

Bupivacaine is widely used as local anesthesia, due to its efficacy in numbing certain organ. Hence, the rising number of surgeries leads to high demand for local anesthesia drugs and is expected to propel the growth of the market.

The hospital pharmacy is expected to dominate the Local Anesthesia drugs market during the forecast period.

The hospital pharmacies held the largest share in the local anesthesia drugs market. This is mainly due to the increasing number of patients suffering from conditions treated in hospitals equipped with advanced infrastructure and adequate facilities. Moreover, the growing number of hospitals and adequate reimbursement policies are also contributing to the growth of this segment.

Geographical Analysis

North America region holds the largest market share global local anesthesia drugs market

North America region is dominating the global-local anesthesia drugs market accounted for the largest market share in 2020. The US anesthesia market is the largest regional market in the world. The market is mainly driven by factors, such as the increasing number of surgeries, rising aging population with increasing chronic conditions, and advancements in anesthesia technologies. Due to the rising scope of local anesthesia in the market, key players are making efforts to develop novel and innovative drugs, thus fueling the market growth in the region

Competitive Landscape

The local anesthesia drugs market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Fresenius Kabi USA, LLC, Pfizer Inc., Advanced Pharma, Inc., Akorn, Inc. Teva Pharmaceutical Industries Ltd., Akorn, Inc., Glenmark Pharmaceuticals, Inc., Baxter international, Inc., and Novartis AG., among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the local anesthesia drugs market globally.

Local Anesthesia Drugs Market Key Companies to Watch

Pfizer Inc.

Overview: Pfizer Inc. (Pfizer), incorporated on June 2, 1942, is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines that improve patients' lives. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology and rare diseases. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. The Company sold its products in over 125 countries.

Product Portfolio: The Company's portfolio comprised of include internal medicine, vaccines, oncology, inflammation and immunology and rare diseases and others.

Why Purchase the Report?

  • Visualize the composition of the local anesthesia drugs market segmentation by drug class, route of administration, distribution channel, and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in local anesthesia drugs market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of local anesthesia drugs market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global local anesthesia drugs market report would provide an access to an approx. 61 market data table, 58 figures and 240 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Local Anesthesia Drugs Market - By Drug Class

  • Bupivacaine
  • Lidocaine
  • Benzocaine
  • Ropivacaine
  • Prilocaine
  • Chloroprocaine
  • Others

Global Local Anesthesia Drugs Market - By Route of Administration

  • Injectable
  • Surface Anesthetic

Global Oral Contraceptive Pills Market - By Distribution Channel

  • Hospital Pharmacy
  • Pharmacy Stores
  • Other

Global Oral Contraceptive Pills Market - By Region

  • North America
  • South America
  • Europe
  • Asia
  • Middle East & Africa

Table of Contents

1. Global Local Anesthesia Drugs Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Local Anesthesia Drugs Market - Market Definition and Overview

3. Global Local Anesthesia Drugs Market - Executive Summary

  • 3.1. Market Snippet by Drug Class
  • 3.2. Market snippet by Route of Administration
  • 3.3. Market Snippet by Distribution Channel
  • 3.4. Market Snippet by Region

4. Global Local Anesthesia Drugs Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising number of surgeries will drive the market growth
      • 4.1.1.2. New approval of anesthetic drugs will drive the market growth
    • 4.1.2. Restraints:
      • 4.1.2.1. Side effects associated with the drugs will hamper the market growth
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Local Anesthesia Drugs Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Local Anesthesia Drugs Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Local Anesthesia Drugs Market - By Drug Class

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class Segment
    • 7.1.2. Market Attractiveness Index, By Drug Class Segment
  • 7.2. Bupivacaine*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Lidocaine
  • 7.4. Benzocaine
  • 7.5. Ropivacaine
  • 7.6. Prilocaine
  • 7.7. Chloroprocaine
  • 7.8. Others

8. Global Local Anesthesia Drugs Market - By Route of Administration

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 8.1.2. Market Attractiveness Index, By Route of Administration
  • 8.2. Injectable*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Surface Anesthetic

9. Global Local Anesthesia Drugs Market - By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment
    • 9.1.2. Market Attractiveness Index, By Distribution Channel Segment
  • 9.2. Hospital Pharmacy *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Pharmacy Stores
    • 9.3.1. Other

10. Global Local Anesthesia Drugs Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6.
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Global Local Anesthesia Drugs Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of key companies to watch
  • 11.5. List of the company with disruptive technology
  • 11.6. List of start-up companies

12. Global Local Anesthesia Drugs Market- Company Profiles

  • 12.1. Fresenius Kabi USA, LLC*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Novartis International AG.
  • 12.3. Pfizer Inc.
  • 12.4. Advanced Pharma, Inc.
  • 12.5. Akorn, Inc.
  • 12.6. Teva Pharmaceutical Industries Ltd.,
  • 12.7. Akorn, Inc.
  • 12.8. Glenmark Pharmaceuticals, Inc.
  • 12.9. Baxter international, Inc.
  • 12.10. Sandoz Inc.

LIST NOT EXHAUSTIVE

13. Global Local Anesthesia Drugs Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us